Skip to main content

Evaluation of the Efficacy of a Recombinant Adenovirus Expressing the Spike Protein of Porcine Epidemic Diarrhea Virus in Pigs.

In recent years, many studies have shown that a live recombinant adenovirus vector-based vaccine is a promising new vaccine candidates against viral infection. Therefore, in this study, a new type of recombinant adenovirus expressing spike (S) protein Cavia Recombinant Proteins pig epidemic diarrhea virus (PEDV), RAD-PEDV-S, produced, and characteristics are determined. 

Then, its efficacy as a vaccine candidate was evaluated in pigs 4-week-old. The results showed that protein S can also be expressed at high levels in the RAD-PEDV-S-infected cells and that the viral titers can reach 1 011 PFU / mL. Furthermore, the results of animal experiments show that the RAD-PEDV-S pose a significant response specific PEDV humoral immunity after vaccination (P <0.05). In addition, RAD-PEDV-S provides partial protection for swine against PEDV extremely lethal challenge. 

The results presented in this study demonstrate that the adenovirus vector can be used as a vaccine vector for vaccine development PEDV and a promising new vaccine candidates for the prevention and control of swine epidemic diarrhea (PED) future, but its efficacy still needs to be improved in the future.
Evaluation of the Efficacy of a Recombinant Adenovirus Expressing the Spike Protein of Porcine Epidemic Diarrhea Virus in Pigs.

Construction and immunological evaluation of a recombinant vaccine expressing Newcastle disease virus highly pathogenic pig reproductive and respiratory syndrome virus GP3 / GP5 protein in pigs.


Highly pathogenic pig reproductive and respiratory syndrome (HP-PRRS) is a significant threat to the pig industry, the vaccination is considered an effective means of prevention and control. Here, we developed two Newcastle disease virus (NDV) Lasota-PRRS vaccine candidate recombinant vectors, rLaSota-GP5 and rLaSota-GP3-GP5, using reverse genetic engineering. 

Both recombinant virus exhibited a high degree of genetic stability after 10 generations in a row in chicken embryos. There are no significant differences in pathogenicity as compared to the parent strain rLaSota in birds, rats and pigs. Recombinant virus can Chicken Recombinant Proteins not be detected in immunized pigs eating environment, but can be detected in the organs and tissues of pigs no more than 10 days after immunization. 

What is important, in contrast with rLaSota-GP5, rLaSota-GP3-GP5 raises both humoral and cellular immune responses are significant in pigs. In particular, neutralizing antibody titers in the group rLaSota-GP3-GP5 is 1.51 times higher than the commercial vaccine group at 42 days post-immunization. At the same time, there are significant differences in the levels of IFN-γ between groups rLaSota-GP3-GP5 and commercial vaccine group
Labels:

Comments

Post a Comment

Popular posts from this blog

Development of Recombinant Protein-Based Vaccine Against Classical Swine Fever Virus in Pigs Using Transgenic Nicotiana benthamiana.

Classical swine fever virus (CSFV) is highly contagious and fatal to infected pigs. Vaccines against CSFV have been developed from inactivated or modified live virus. The vaccine is effective for immunization of animals, but they are associated with E.coli Recombinant Proteins  problems such as accidental spread of animal viruses in the field, and with trade barriers following vaccination. Here, we report the generation of transgenic Nicotiana benthamiana plants for large-scale, cost-effective production E2 fusion proteins for use as a recombinant vaccine against CSFV in pigs. Transgenic N. benthamiana plants save an intergenic, single-copy insertion of a chimeric gene encoding a fusion protein E2 has a high level of expression of the transgene. For large-scale production of the fusion protein E2 leaf tissue, we developed protein purification protocol consisting of a cellulose-binding domain (CBD) -cellulose affinity based purification and size-exclusion gel filtration chromatography
Post a Comment
Read more

Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.

Despite the improvements in time and approach to early reperfusion in acute coronary syndromes occur, culminating myocardial injury in myocardial infarction (MI) remains a common event. Despite the multifactorial process, the imbalance between the induction of proteolytic pathways, such as matrix metalloproteinases ( MMPs) and endogenous tissu e inhibitors Ovine Recombinant Proteins  of metalloproteinases (TIMPs), have been shown to contribute to this process.  In this study, a full-length recombinant TIMP-3 protein (rTIMP-3) are packed in a specially formulated hyaluronic acid (HA) based hydrogel containing MMP-cleavable peptide cross-links, which affects the level of rTIMP- 3 release of the HA gel , Effects of local delivery of MMP-sensitive HA this gel (HAMMPS) alone and contains rTIMP-3 (HAMMPS / rTIMP-3) examined in terms of the natural history of post-MI remodeling.  Pigs were randomized to one of the following three distinct groups: MI and injection of saline (MI / saline group,
Post a Comment
Read more